PHARMACOLOGICAL RESEARCH-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2106882, encodeId=0deb2106882a4, content=大佬们，2022年这杂志几区, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9d935707939, createdName=ms7000000249495571, createdTime=Wed Dec 21 09:02:40 CST 2022, time=2022-12-21, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2101875, encodeId=93f921018e575, content=大佬们，publishing option 没仔细看选的Open Access，但是文章还在修回，接受之前还能改吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c0ab2096768, createdName=Yancie JAY, createdTime=Mon Nov 21 23:39:27 CST 2022, time=2022-11-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2090185, encodeId=598220901853b, content=22号Required Reviews Completed，24号又变成under review，什么情况？？？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6cb35421011, createdName=ms1000001879726925, createdTime=Sat Sep 24 20:36:18 CST 2022, time=2022-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2100419, encodeId=a7aa2100419cd, content=从required reviews completed又变成Under Review是什么意思, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d98e3553833, createdName=1325af9cm73暂无昵称, createdTime=Mon Nov 14 14:57:31 CST 2022, time=2022-11-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2097209, encodeId=1964209e209e7, content=偏重的研究方向：机制;分子机制 经验分享：投稿的时候需要原始数据吗？还是修回的时候需要？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKt8ibGpwDuX7CGf4Nf1iaeHbqWV9NQUmj1teVPeX2aMx1ic2dghlvnV2TFXibFY7SyCCAl8iaPyicrNOQA/0, createdBy=54821701295, createdName=毛毛们, createdTime=Sat Oct 29 07:39:03 CST 2022, time=2022-10-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1227970, encodeId=5ce9122e97005, content=06-08投稿的，9号就到编辑手里了，现在还是没动，也没拒也没送外审，这是正常的吗，不是说这个杂志很快的吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f3bd5428103, createdName=ms7000002114122850, createdTime=Wed Jun 22 12:05:06 CST 2022, time=2022-06-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=573553, encodeId=949e5e3553b7, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：2.25 submitted 2.25 under review 4.24 major revision 6.13 minor revision 6.25 minor revision 7.11 accept 7.11 send to production, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=257, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9fca1672711, createdName=SamuelWoo, createdTime=Thu Jul 11 00:00:00 CST 2019, time=2019-07-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=575525, encodeId=12695e5525a7, content=问下你的文章现在接收了吗？我的投出去当天编辑推荐换他写的题目，并在摘要里从新加了一句话她加的话后重新投稿，重投二天后目前还在with editor，请问这个状态持续多久才能under review莫名字阔以吗 2019-08-16 00:00:00 发表: 可以问问了吧，他家挺快的啊，我当天就邀请审稿人了, beContent=莫名字阔以吗 2019-08-16 00:00:00 发表: 可以问问了吧，他家挺快的啊，我当天就邀请审稿人了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKbuMTogxT82iaafNzKneXa0pOJ6F14K57vK0W8Loxkibl2ZfjgtmlJbEFbpIv4qpjuqhhoK05tzibWw/132, createdBy=89622105481, createdName=一梦十寒, createdTime=Thu Aug 29 00:00:00 CST 2019, time=2019-08-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1227018, encodeId=281c122e0181b, content=请问Pharmacological Research的投稿网址在哪里可以找到呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b9775425788, createdName=ms9000002027311925, createdTime=Fri Jun 17 12:57:56 CST 2022, time=2022-06-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1232803, encodeId=41b11232803d1, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：拒稿后修改重新投稿;综述 经验分享：请问一下友友，这个杂志送外审后拒稿率高吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220703/ac30326af85e40a198bd59fb829e58e1/640aec889c7a46399361ab5ac03a87e9.jpg, createdBy=720f2366630, createdName=待我慢慢, createdTime=Sat Jul 16 15:37:22 CST 2022, time=2022-07-16, status=1, ipAttribution=)]

2022-12-21 ms7000000249495571 来自广东省

大佬们，2022年这杂志几区

39 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2106882, encodeId=0deb2106882a4, content=大佬们，2022年这杂志几区, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9d935707939, createdName=ms7000000249495571, createdTime=Wed Dec 21 09:02:40 CST 2022, time=2022-12-21, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2101875, encodeId=93f921018e575, content=大佬们，publishing option 没仔细看选的Open Access，但是文章还在修回，接受之前还能改吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c0ab2096768, createdName=Yancie JAY, createdTime=Mon Nov 21 23:39:27 CST 2022, time=2022-11-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2090185, encodeId=598220901853b, content=22号Required Reviews Completed，24号又变成under review，什么情况？？？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6cb35421011, createdName=ms1000001879726925, createdTime=Sat Sep 24 20:36:18 CST 2022, time=2022-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2100419, encodeId=a7aa2100419cd, content=从required reviews completed又变成Under Review是什么意思, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d98e3553833, createdName=1325af9cm73暂无昵称, createdTime=Mon Nov 14 14:57:31 CST 2022, time=2022-11-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2097209, encodeId=1964209e209e7, content=偏重的研究方向：机制;分子机制 经验分享：投稿的时候需要原始数据吗？还是修回的时候需要？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKt8ibGpwDuX7CGf4Nf1iaeHbqWV9NQUmj1teVPeX2aMx1ic2dghlvnV2TFXibFY7SyCCAl8iaPyicrNOQA/0, createdBy=54821701295, createdName=毛毛们, createdTime=Sat Oct 29 07:39:03 CST 2022, time=2022-10-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1227970, encodeId=5ce9122e97005, content=06-08投稿的，9号就到编辑手里了，现在还是没动，也没拒也没送外审，这是正常的吗，不是说这个杂志很快的吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f3bd5428103, createdName=ms7000002114122850, createdTime=Wed Jun 22 12:05:06 CST 2022, time=2022-06-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=573553, encodeId=949e5e3553b7, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：2.25 submitted 2.25 under review 4.24 major revision 6.13 minor revision 6.25 minor revision 7.11 accept 7.11 send to production, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=257, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9fca1672711, createdName=SamuelWoo, createdTime=Thu Jul 11 00:00:00 CST 2019, time=2019-07-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=575525, encodeId=12695e5525a7, content=问下你的文章现在接收了吗？我的投出去当天编辑推荐换他写的题目，并在摘要里从新加了一句话她加的话后重新投稿，重投二天后目前还在with editor，请问这个状态持续多久才能under review莫名字阔以吗 2019-08-16 00:00:00 发表: 可以问问了吧，他家挺快的啊，我当天就邀请审稿人了, beContent=莫名字阔以吗 2019-08-16 00:00:00 发表: 可以问问了吧，他家挺快的啊，我当天就邀请审稿人了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKbuMTogxT82iaafNzKneXa0pOJ6F14K57vK0W8Loxkibl2ZfjgtmlJbEFbpIv4qpjuqhhoK05tzibWw/132, createdBy=89622105481, createdName=一梦十寒, createdTime=Thu Aug 29 00:00:00 CST 2019, time=2019-08-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1227018, encodeId=281c122e0181b, content=请问Pharmacological Research的投稿网址在哪里可以找到呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b9775425788, createdName=ms9000002027311925, createdTime=Fri Jun 17 12:57:56 CST 2022, time=2022-06-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1232803, encodeId=41b11232803d1, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：拒稿后修改重新投稿;综述 经验分享：请问一下友友，这个杂志送外审后拒稿率高吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220703/ac30326af85e40a198bd59fb829e58e1/640aec889c7a46399361ab5ac03a87e9.jpg, createdBy=720f2366630, createdName=待我慢慢, createdTime=Sat Jul 16 15:37:22 CST 2022, time=2022-07-16, status=1, ipAttribution=)]

2022-11-21 Yancie JAY

大佬们，publishing option 没仔细看选的Open Access，但是文章还在修回，接受之前还能改吗？

41 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2106882, encodeId=0deb2106882a4, content=大佬们，2022年这杂志几区, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9d935707939, createdName=ms7000000249495571, createdTime=Wed Dec 21 09:02:40 CST 2022, time=2022-12-21, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2101875, encodeId=93f921018e575, content=大佬们，publishing option 没仔细看选的Open Access，但是文章还在修回，接受之前还能改吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c0ab2096768, createdName=Yancie JAY, createdTime=Mon Nov 21 23:39:27 CST 2022, time=2022-11-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2090185, encodeId=598220901853b, content=22号Required Reviews Completed，24号又变成under review，什么情况？？？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6cb35421011, createdName=ms1000001879726925, createdTime=Sat Sep 24 20:36:18 CST 2022, time=2022-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2100419, encodeId=a7aa2100419cd, content=从required reviews completed又变成Under Review是什么意思, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d98e3553833, createdName=1325af9cm73暂无昵称, createdTime=Mon Nov 14 14:57:31 CST 2022, time=2022-11-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2097209, encodeId=1964209e209e7, content=偏重的研究方向：机制;分子机制 经验分享：投稿的时候需要原始数据吗？还是修回的时候需要？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKt8ibGpwDuX7CGf4Nf1iaeHbqWV9NQUmj1teVPeX2aMx1ic2dghlvnV2TFXibFY7SyCCAl8iaPyicrNOQA/0, createdBy=54821701295, createdName=毛毛们, createdTime=Sat Oct 29 07:39:03 CST 2022, time=2022-10-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1227970, encodeId=5ce9122e97005, content=06-08投稿的，9号就到编辑手里了，现在还是没动，也没拒也没送外审，这是正常的吗，不是说这个杂志很快的吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f3bd5428103, createdName=ms7000002114122850, createdTime=Wed Jun 22 12:05:06 CST 2022, time=2022-06-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=573553, encodeId=949e5e3553b7, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：2.25 submitted 2.25 under review 4.24 major revision 6.13 minor revision 6.25 minor revision 7.11 accept 7.11 send to production, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=257, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9fca1672711, createdName=SamuelWoo, createdTime=Thu Jul 11 00:00:00 CST 2019, time=2019-07-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=575525, encodeId=12695e5525a7, content=问下你的文章现在接收了吗？我的投出去当天编辑推荐换他写的题目，并在摘要里从新加了一句话她加的话后重新投稿，重投二天后目前还在with editor，请问这个状态持续多久才能under review莫名字阔以吗 2019-08-16 00:00:00 发表: 可以问问了吧，他家挺快的啊，我当天就邀请审稿人了, beContent=莫名字阔以吗 2019-08-16 00:00:00 发表: 可以问问了吧，他家挺快的啊，我当天就邀请审稿人了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKbuMTogxT82iaafNzKneXa0pOJ6F14K57vK0W8Loxkibl2ZfjgtmlJbEFbpIv4qpjuqhhoK05tzibWw/132, createdBy=89622105481, createdName=一梦十寒, createdTime=Thu Aug 29 00:00:00 CST 2019, time=2019-08-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1227018, encodeId=281c122e0181b, content=请问Pharmacological Research的投稿网址在哪里可以找到呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b9775425788, createdName=ms9000002027311925, createdTime=Fri Jun 17 12:57:56 CST 2022, time=2022-06-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1232803, encodeId=41b11232803d1, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：拒稿后修改重新投稿;综述 经验分享：请问一下友友，这个杂志送外审后拒稿率高吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220703/ac30326af85e40a198bd59fb829e58e1/640aec889c7a46399361ab5ac03a87e9.jpg, createdBy=720f2366630, createdName=待我慢慢, createdTime=Sat Jul 16 15:37:22 CST 2022, time=2022-07-16, status=1, ipAttribution=)]

2022-09-24 ms1000001879726925

22号Required Reviews Completed，24号又变成under review，什么情况？？？

40 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2106882, encodeId=0deb2106882a4, content=大佬们，2022年这杂志几区, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9d935707939, createdName=ms7000000249495571, createdTime=Wed Dec 21 09:02:40 CST 2022, time=2022-12-21, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2101875, encodeId=93f921018e575, content=大佬们，publishing option 没仔细看选的Open Access，但是文章还在修回，接受之前还能改吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c0ab2096768, createdName=Yancie JAY, createdTime=Mon Nov 21 23:39:27 CST 2022, time=2022-11-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2090185, encodeId=598220901853b, content=22号Required Reviews Completed，24号又变成under review，什么情况？？？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6cb35421011, createdName=ms1000001879726925, createdTime=Sat Sep 24 20:36:18 CST 2022, time=2022-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2100419, encodeId=a7aa2100419cd, content=从required reviews completed又变成Under Review是什么意思, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d98e3553833, createdName=1325af9cm73暂无昵称, createdTime=Mon Nov 14 14:57:31 CST 2022, time=2022-11-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2097209, encodeId=1964209e209e7, content=偏重的研究方向：机制;分子机制 经验分享：投稿的时候需要原始数据吗？还是修回的时候需要？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKt8ibGpwDuX7CGf4Nf1iaeHbqWV9NQUmj1teVPeX2aMx1ic2dghlvnV2TFXibFY7SyCCAl8iaPyicrNOQA/0, createdBy=54821701295, createdName=毛毛们, createdTime=Sat Oct 29 07:39:03 CST 2022, time=2022-10-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1227970, encodeId=5ce9122e97005, content=06-08投稿的，9号就到编辑手里了，现在还是没动，也没拒也没送外审，这是正常的吗，不是说这个杂志很快的吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f3bd5428103, createdName=ms7000002114122850, createdTime=Wed Jun 22 12:05:06 CST 2022, time=2022-06-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=573553, encodeId=949e5e3553b7, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：2.25 submitted 2.25 under review 4.24 major revision 6.13 minor revision 6.25 minor revision 7.11 accept 7.11 send to production, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=257, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9fca1672711, createdName=SamuelWoo, createdTime=Thu Jul 11 00:00:00 CST 2019, time=2019-07-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=575525, encodeId=12695e5525a7, content=问下你的文章现在接收了吗？我的投出去当天编辑推荐换他写的题目，并在摘要里从新加了一句话她加的话后重新投稿，重投二天后目前还在with editor，请问这个状态持续多久才能under review莫名字阔以吗 2019-08-16 00:00:00 发表: 可以问问了吧，他家挺快的啊，我当天就邀请审稿人了, beContent=莫名字阔以吗 2019-08-16 00:00:00 发表: 可以问问了吧，他家挺快的啊，我当天就邀请审稿人了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKbuMTogxT82iaafNzKneXa0pOJ6F14K57vK0W8Loxkibl2ZfjgtmlJbEFbpIv4qpjuqhhoK05tzibWw/132, createdBy=89622105481, createdName=一梦十寒, createdTime=Thu Aug 29 00:00:00 CST 2019, time=2019-08-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1227018, encodeId=281c122e0181b, content=请问Pharmacological Research的投稿网址在哪里可以找到呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b9775425788, createdName=ms9000002027311925, createdTime=Fri Jun 17 12:57:56 CST 2022, time=2022-06-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1232803, encodeId=41b11232803d1, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：拒稿后修改重新投稿;综述 经验分享：请问一下友友，这个杂志送外审后拒稿率高吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220703/ac30326af85e40a198bd59fb829e58e1/640aec889c7a46399361ab5ac03a87e9.jpg, createdBy=720f2366630, createdName=待我慢慢, createdTime=Sat Jul 16 15:37:22 CST 2022, time=2022-07-16, status=1, ipAttribution=)]

2022-11-14 1325af9cm73暂无昵称

从required reviews completed又变成Under Review是什么意思

30 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2106882, encodeId=0deb2106882a4, content=大佬们，2022年这杂志几区, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9d935707939, createdName=ms7000000249495571, createdTime=Wed Dec 21 09:02:40 CST 2022, time=2022-12-21, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2101875, encodeId=93f921018e575, content=大佬们，publishing option 没仔细看选的Open Access，但是文章还在修回，接受之前还能改吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c0ab2096768, createdName=Yancie JAY, createdTime=Mon Nov 21 23:39:27 CST 2022, time=2022-11-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2090185, encodeId=598220901853b, content=22号Required Reviews Completed，24号又变成under review，什么情况？？？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6cb35421011, createdName=ms1000001879726925, createdTime=Sat Sep 24 20:36:18 CST 2022, time=2022-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2100419, encodeId=a7aa2100419cd, content=从required reviews completed又变成Under Review是什么意思, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d98e3553833, createdName=1325af9cm73暂无昵称, createdTime=Mon Nov 14 14:57:31 CST 2022, time=2022-11-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2097209, encodeId=1964209e209e7, content=偏重的研究方向：机制;分子机制 经验分享：投稿的时候需要原始数据吗？还是修回的时候需要？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKt8ibGpwDuX7CGf4Nf1iaeHbqWV9NQUmj1teVPeX2aMx1ic2dghlvnV2TFXibFY7SyCCAl8iaPyicrNOQA/0, createdBy=54821701295, createdName=毛毛们, createdTime=Sat Oct 29 07:39:03 CST 2022, time=2022-10-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1227970, encodeId=5ce9122e97005, content=06-08投稿的，9号就到编辑手里了，现在还是没动，也没拒也没送外审，这是正常的吗，不是说这个杂志很快的吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f3bd5428103, createdName=ms7000002114122850, createdTime=Wed Jun 22 12:05:06 CST 2022, time=2022-06-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=573553, encodeId=949e5e3553b7, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：2.25 submitted 2.25 under review 4.24 major revision 6.13 minor revision 6.25 minor revision 7.11 accept 7.11 send to production, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=257, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9fca1672711, createdName=SamuelWoo, createdTime=Thu Jul 11 00:00:00 CST 2019, time=2019-07-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=575525, encodeId=12695e5525a7, content=问下你的文章现在接收了吗？我的投出去当天编辑推荐换他写的题目，并在摘要里从新加了一句话她加的话后重新投稿，重投二天后目前还在with editor，请问这个状态持续多久才能under review莫名字阔以吗 2019-08-16 00:00:00 发表: 可以问问了吧，他家挺快的啊，我当天就邀请审稿人了, beContent=莫名字阔以吗 2019-08-16 00:00:00 发表: 可以问问了吧，他家挺快的啊，我当天就邀请审稿人了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKbuMTogxT82iaafNzKneXa0pOJ6F14K57vK0W8Loxkibl2ZfjgtmlJbEFbpIv4qpjuqhhoK05tzibWw/132, createdBy=89622105481, createdName=一梦十寒, createdTime=Thu Aug 29 00:00:00 CST 2019, time=2019-08-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1227018, encodeId=281c122e0181b, content=请问Pharmacological Research的投稿网址在哪里可以找到呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b9775425788, createdName=ms9000002027311925, createdTime=Fri Jun 17 12:57:56 CST 2022, time=2022-06-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1232803, encodeId=41b11232803d1, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：拒稿后修改重新投稿;综述 经验分享：请问一下友友，这个杂志送外审后拒稿率高吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220703/ac30326af85e40a198bd59fb829e58e1/640aec889c7a46399361ab5ac03a87e9.jpg, createdBy=720f2366630, createdName=待我慢慢, createdTime=Sat Jul 16 15:37:22 CST 2022, time=2022-07-16, status=1, ipAttribution=)]

2022-10-29 毛毛们

偏重的研究方向：机制;分子机制
经验分享：投稿的时候需要原始数据吗？还是修回的时候需要？

36 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2106882, encodeId=0deb2106882a4, content=大佬们，2022年这杂志几区, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9d935707939, createdName=ms7000000249495571, createdTime=Wed Dec 21 09:02:40 CST 2022, time=2022-12-21, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2101875, encodeId=93f921018e575, content=大佬们，publishing option 没仔细看选的Open Access，但是文章还在修回，接受之前还能改吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c0ab2096768, createdName=Yancie JAY, createdTime=Mon Nov 21 23:39:27 CST 2022, time=2022-11-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2090185, encodeId=598220901853b, content=22号Required Reviews Completed，24号又变成under review，什么情况？？？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6cb35421011, createdName=ms1000001879726925, createdTime=Sat Sep 24 20:36:18 CST 2022, time=2022-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2100419, encodeId=a7aa2100419cd, content=从required reviews completed又变成Under Review是什么意思, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d98e3553833, createdName=1325af9cm73暂无昵称, createdTime=Mon Nov 14 14:57:31 CST 2022, time=2022-11-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2097209, encodeId=1964209e209e7, content=偏重的研究方向：机制;分子机制 经验分享：投稿的时候需要原始数据吗？还是修回的时候需要？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKt8ibGpwDuX7CGf4Nf1iaeHbqWV9NQUmj1teVPeX2aMx1ic2dghlvnV2TFXibFY7SyCCAl8iaPyicrNOQA/0, createdBy=54821701295, createdName=毛毛们, createdTime=Sat Oct 29 07:39:03 CST 2022, time=2022-10-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1227970, encodeId=5ce9122e97005, content=06-08投稿的，9号就到编辑手里了，现在还是没动，也没拒也没送外审，这是正常的吗，不是说这个杂志很快的吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f3bd5428103, createdName=ms7000002114122850, createdTime=Wed Jun 22 12:05:06 CST 2022, time=2022-06-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=573553, encodeId=949e5e3553b7, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：2.25 submitted 2.25 under review 4.24 major revision 6.13 minor revision 6.25 minor revision 7.11 accept 7.11 send to production, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=257, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9fca1672711, createdName=SamuelWoo, createdTime=Thu Jul 11 00:00:00 CST 2019, time=2019-07-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=575525, encodeId=12695e5525a7, content=问下你的文章现在接收了吗？我的投出去当天编辑推荐换他写的题目，并在摘要里从新加了一句话她加的话后重新投稿，重投二天后目前还在with editor，请问这个状态持续多久才能under review莫名字阔以吗 2019-08-16 00:00:00 发表: 可以问问了吧，他家挺快的啊，我当天就邀请审稿人了, beContent=莫名字阔以吗 2019-08-16 00:00:00 发表: 可以问问了吧，他家挺快的啊，我当天就邀请审稿人了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKbuMTogxT82iaafNzKneXa0pOJ6F14K57vK0W8Loxkibl2ZfjgtmlJbEFbpIv4qpjuqhhoK05tzibWw/132, createdBy=89622105481, createdName=一梦十寒, createdTime=Thu Aug 29 00:00:00 CST 2019, time=2019-08-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1227018, encodeId=281c122e0181b, content=请问Pharmacological Research的投稿网址在哪里可以找到呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b9775425788, createdName=ms9000002027311925, createdTime=Fri Jun 17 12:57:56 CST 2022, time=2022-06-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1232803, encodeId=41b11232803d1, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：拒稿后修改重新投稿;综述 经验分享：请问一下友友，这个杂志送外审后拒稿率高吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220703/ac30326af85e40a198bd59fb829e58e1/640aec889c7a46399361ab5ac03a87e9.jpg, createdBy=720f2366630, createdName=待我慢慢, createdTime=Sat Jul 16 15:37:22 CST 2022, time=2022-07-16, status=1, ipAttribution=)]

2022-06-22 ms7000002114122850

06-08投稿的，9号就到编辑手里了，现在还是没动，也没拒也没送外审，这是正常的吗，不是说这个杂志很快的吗

64 5

展开5条回复

[GetPortalCommentsPageByObjectIdResponse(id=2106882, encodeId=0deb2106882a4, content=大佬们，2022年这杂志几区, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9d935707939, createdName=ms7000000249495571, createdTime=Wed Dec 21 09:02:40 CST 2022, time=2022-12-21, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2101875, encodeId=93f921018e575, content=大佬们，publishing option 没仔细看选的Open Access，但是文章还在修回，接受之前还能改吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c0ab2096768, createdName=Yancie JAY, createdTime=Mon Nov 21 23:39:27 CST 2022, time=2022-11-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2090185, encodeId=598220901853b, content=22号Required Reviews Completed，24号又变成under review，什么情况？？？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6cb35421011, createdName=ms1000001879726925, createdTime=Sat Sep 24 20:36:18 CST 2022, time=2022-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2100419, encodeId=a7aa2100419cd, content=从required reviews completed又变成Under Review是什么意思, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d98e3553833, createdName=1325af9cm73暂无昵称, createdTime=Mon Nov 14 14:57:31 CST 2022, time=2022-11-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2097209, encodeId=1964209e209e7, content=偏重的研究方向：机制;分子机制 经验分享：投稿的时候需要原始数据吗？还是修回的时候需要？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKt8ibGpwDuX7CGf4Nf1iaeHbqWV9NQUmj1teVPeX2aMx1ic2dghlvnV2TFXibFY7SyCCAl8iaPyicrNOQA/0, createdBy=54821701295, createdName=毛毛们, createdTime=Sat Oct 29 07:39:03 CST 2022, time=2022-10-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1227970, encodeId=5ce9122e97005, content=06-08投稿的，9号就到编辑手里了，现在还是没动，也没拒也没送外审，这是正常的吗，不是说这个杂志很快的吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f3bd5428103, createdName=ms7000002114122850, createdTime=Wed Jun 22 12:05:06 CST 2022, time=2022-06-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=573553, encodeId=949e5e3553b7, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：2.25 submitted 2.25 under review 4.24 major revision 6.13 minor revision 6.25 minor revision 7.11 accept 7.11 send to production, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=257, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9fca1672711, createdName=SamuelWoo, createdTime=Thu Jul 11 00:00:00 CST 2019, time=2019-07-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=575525, encodeId=12695e5525a7, content=问下你的文章现在接收了吗？我的投出去当天编辑推荐换他写的题目，并在摘要里从新加了一句话她加的话后重新投稿，重投二天后目前还在with editor，请问这个状态持续多久才能under review莫名字阔以吗 2019-08-16 00:00:00 发表: 可以问问了吧，他家挺快的啊，我当天就邀请审稿人了, beContent=莫名字阔以吗 2019-08-16 00:00:00 发表: 可以问问了吧，他家挺快的啊，我当天就邀请审稿人了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKbuMTogxT82iaafNzKneXa0pOJ6F14K57vK0W8Loxkibl2ZfjgtmlJbEFbpIv4qpjuqhhoK05tzibWw/132, createdBy=89622105481, createdName=一梦十寒, createdTime=Thu Aug 29 00:00:00 CST 2019, time=2019-08-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1227018, encodeId=281c122e0181b, content=请问Pharmacological Research的投稿网址在哪里可以找到呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b9775425788, createdName=ms9000002027311925, createdTime=Fri Jun 17 12:57:56 CST 2022, time=2022-06-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1232803, encodeId=41b11232803d1, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：拒稿后修改重新投稿;综述 经验分享：请问一下友友，这个杂志送外审后拒稿率高吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220703/ac30326af85e40a198bd59fb829e58e1/640aec889c7a46399361ab5ac03a87e9.jpg, createdBy=720f2366630, createdName=待我慢慢, createdTime=Sat Jul 16 15:37:22 CST 2022, time=2022-07-16, status=1, ipAttribution=)]

2019-07-11 SamuelWoo

审稿速度:2.0 | 投稿命中率:50.0
经验分享：2.25 submitted 2.25 under review 4.24 major revision 6.13 minor revision 6.25 minor revision 7.11 accept 7.11 send to production

257 5

展开5条回复

[GetPortalCommentsPageByObjectIdResponse(id=2106882, encodeId=0deb2106882a4, content=大佬们，2022年这杂志几区, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9d935707939, createdName=ms7000000249495571, createdTime=Wed Dec 21 09:02:40 CST 2022, time=2022-12-21, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2101875, encodeId=93f921018e575, content=大佬们，publishing option 没仔细看选的Open Access，但是文章还在修回，接受之前还能改吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c0ab2096768, createdName=Yancie JAY, createdTime=Mon Nov 21 23:39:27 CST 2022, time=2022-11-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2090185, encodeId=598220901853b, content=22号Required Reviews Completed，24号又变成under review，什么情况？？？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6cb35421011, createdName=ms1000001879726925, createdTime=Sat Sep 24 20:36:18 CST 2022, time=2022-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2100419, encodeId=a7aa2100419cd, content=从required reviews completed又变成Under Review是什么意思, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d98e3553833, createdName=1325af9cm73暂无昵称, createdTime=Mon Nov 14 14:57:31 CST 2022, time=2022-11-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2097209, encodeId=1964209e209e7, content=偏重的研究方向：机制;分子机制 经验分享：投稿的时候需要原始数据吗？还是修回的时候需要？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKt8ibGpwDuX7CGf4Nf1iaeHbqWV9NQUmj1teVPeX2aMx1ic2dghlvnV2TFXibFY7SyCCAl8iaPyicrNOQA/0, createdBy=54821701295, createdName=毛毛们, createdTime=Sat Oct 29 07:39:03 CST 2022, time=2022-10-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1227970, encodeId=5ce9122e97005, content=06-08投稿的，9号就到编辑手里了，现在还是没动，也没拒也没送外审，这是正常的吗，不是说这个杂志很快的吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f3bd5428103, createdName=ms7000002114122850, createdTime=Wed Jun 22 12:05:06 CST 2022, time=2022-06-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=573553, encodeId=949e5e3553b7, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：2.25 submitted 2.25 under review 4.24 major revision 6.13 minor revision 6.25 minor revision 7.11 accept 7.11 send to production, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=257, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9fca1672711, createdName=SamuelWoo, createdTime=Thu Jul 11 00:00:00 CST 2019, time=2019-07-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=575525, encodeId=12695e5525a7, content=问下你的文章现在接收了吗？我的投出去当天编辑推荐换他写的题目，并在摘要里从新加了一句话她加的话后重新投稿，重投二天后目前还在with editor，请问这个状态持续多久才能under review莫名字阔以吗 2019-08-16 00:00:00 发表: 可以问问了吧，他家挺快的啊，我当天就邀请审稿人了, beContent=莫名字阔以吗 2019-08-16 00:00:00 发表: 可以问问了吧，他家挺快的啊，我当天就邀请审稿人了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKbuMTogxT82iaafNzKneXa0pOJ6F14K57vK0W8Loxkibl2ZfjgtmlJbEFbpIv4qpjuqhhoK05tzibWw/132, createdBy=89622105481, createdName=一梦十寒, createdTime=Thu Aug 29 00:00:00 CST 2019, time=2019-08-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1227018, encodeId=281c122e0181b, content=请问Pharmacological Research的投稿网址在哪里可以找到呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b9775425788, createdName=ms9000002027311925, createdTime=Fri Jun 17 12:57:56 CST 2022, time=2022-06-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1232803, encodeId=41b11232803d1, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：拒稿后修改重新投稿;综述 经验分享：请问一下友友，这个杂志送外审后拒稿率高吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220703/ac30326af85e40a198bd59fb829e58e1/640aec889c7a46399361ab5ac03a87e9.jpg, createdBy=720f2366630, createdName=待我慢慢, createdTime=Sat Jul 16 15:37:22 CST 2022, time=2022-07-16, status=1, ipAttribution=)]

2019-08-29 一梦十寒

问下你的文章现在接收了吗？我的投出去当天编辑推荐换他写的题目，并在摘要里从新加了一句话她加的话后重新投稿，重投二天后目前还在with editor，请问这个状态持续多久才能under review莫名字阔以吗 2019-08-16 00:00:00 发表:
可以问问了吧，他家挺快的啊，我当天就邀请审稿人了

莫名字阔以吗 2019-08-16 00:00:00 发表: 可以问问了吧，他家挺快的啊，我当天就邀请审稿人了

117 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2106882, encodeId=0deb2106882a4, content=大佬们，2022年这杂志几区, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9d935707939, createdName=ms7000000249495571, createdTime=Wed Dec 21 09:02:40 CST 2022, time=2022-12-21, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2101875, encodeId=93f921018e575, content=大佬们，publishing option 没仔细看选的Open Access，但是文章还在修回，接受之前还能改吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c0ab2096768, createdName=Yancie JAY, createdTime=Mon Nov 21 23:39:27 CST 2022, time=2022-11-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2090185, encodeId=598220901853b, content=22号Required Reviews Completed，24号又变成under review，什么情况？？？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6cb35421011, createdName=ms1000001879726925, createdTime=Sat Sep 24 20:36:18 CST 2022, time=2022-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2100419, encodeId=a7aa2100419cd, content=从required reviews completed又变成Under Review是什么意思, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d98e3553833, createdName=1325af9cm73暂无昵称, createdTime=Mon Nov 14 14:57:31 CST 2022, time=2022-11-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2097209, encodeId=1964209e209e7, content=偏重的研究方向：机制;分子机制 经验分享：投稿的时候需要原始数据吗？还是修回的时候需要？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKt8ibGpwDuX7CGf4Nf1iaeHbqWV9NQUmj1teVPeX2aMx1ic2dghlvnV2TFXibFY7SyCCAl8iaPyicrNOQA/0, createdBy=54821701295, createdName=毛毛们, createdTime=Sat Oct 29 07:39:03 CST 2022, time=2022-10-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1227970, encodeId=5ce9122e97005, content=06-08投稿的，9号就到编辑手里了，现在还是没动，也没拒也没送外审，这是正常的吗，不是说这个杂志很快的吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f3bd5428103, createdName=ms7000002114122850, createdTime=Wed Jun 22 12:05:06 CST 2022, time=2022-06-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=573553, encodeId=949e5e3553b7, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：2.25 submitted 2.25 under review 4.24 major revision 6.13 minor revision 6.25 minor revision 7.11 accept 7.11 send to production, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=257, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9fca1672711, createdName=SamuelWoo, createdTime=Thu Jul 11 00:00:00 CST 2019, time=2019-07-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=575525, encodeId=12695e5525a7, content=问下你的文章现在接收了吗？我的投出去当天编辑推荐换他写的题目，并在摘要里从新加了一句话她加的话后重新投稿，重投二天后目前还在with editor，请问这个状态持续多久才能under review莫名字阔以吗 2019-08-16 00:00:00 发表: 可以问问了吧，他家挺快的啊，我当天就邀请审稿人了, beContent=莫名字阔以吗 2019-08-16 00:00:00 发表: 可以问问了吧，他家挺快的啊，我当天就邀请审稿人了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKbuMTogxT82iaafNzKneXa0pOJ6F14K57vK0W8Loxkibl2ZfjgtmlJbEFbpIv4qpjuqhhoK05tzibWw/132, createdBy=89622105481, createdName=一梦十寒, createdTime=Thu Aug 29 00:00:00 CST 2019, time=2019-08-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1227018, encodeId=281c122e0181b, content=请问Pharmacological Research的投稿网址在哪里可以找到呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b9775425788, createdName=ms9000002027311925, createdTime=Fri Jun 17 12:57:56 CST 2022, time=2022-06-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1232803, encodeId=41b11232803d1, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：拒稿后修改重新投稿;综述 经验分享：请问一下友友，这个杂志送外审后拒稿率高吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220703/ac30326af85e40a198bd59fb829e58e1/640aec889c7a46399361ab5ac03a87e9.jpg, createdBy=720f2366630, createdName=待我慢慢, createdTime=Sat Jul 16 15:37:22 CST 2022, time=2022-07-16, status=1, ipAttribution=)]

2022-06-17 ms9000002027311925

请问Pharmacological Research的投稿网址在哪里可以找到呀

30 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2106882, encodeId=0deb2106882a4, content=大佬们，2022年这杂志几区, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9d935707939, createdName=ms7000000249495571, createdTime=Wed Dec 21 09:02:40 CST 2022, time=2022-12-21, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2101875, encodeId=93f921018e575, content=大佬们，publishing option 没仔细看选的Open Access，但是文章还在修回，接受之前还能改吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c0ab2096768, createdName=Yancie JAY, createdTime=Mon Nov 21 23:39:27 CST 2022, time=2022-11-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2090185, encodeId=598220901853b, content=22号Required Reviews Completed，24号又变成under review，什么情况？？？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6cb35421011, createdName=ms1000001879726925, createdTime=Sat Sep 24 20:36:18 CST 2022, time=2022-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2100419, encodeId=a7aa2100419cd, content=从required reviews completed又变成Under Review是什么意思, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d98e3553833, createdName=1325af9cm73暂无昵称, createdTime=Mon Nov 14 14:57:31 CST 2022, time=2022-11-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2097209, encodeId=1964209e209e7, content=偏重的研究方向：机制;分子机制 经验分享：投稿的时候需要原始数据吗？还是修回的时候需要？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKt8ibGpwDuX7CGf4Nf1iaeHbqWV9NQUmj1teVPeX2aMx1ic2dghlvnV2TFXibFY7SyCCAl8iaPyicrNOQA/0, createdBy=54821701295, createdName=毛毛们, createdTime=Sat Oct 29 07:39:03 CST 2022, time=2022-10-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1227970, encodeId=5ce9122e97005, content=06-08投稿的，9号就到编辑手里了，现在还是没动，也没拒也没送外审，这是正常的吗，不是说这个杂志很快的吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f3bd5428103, createdName=ms7000002114122850, createdTime=Wed Jun 22 12:05:06 CST 2022, time=2022-06-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=573553, encodeId=949e5e3553b7, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：2.25 submitted 2.25 under review 4.24 major revision 6.13 minor revision 6.25 minor revision 7.11 accept 7.11 send to production, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=257, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9fca1672711, createdName=SamuelWoo, createdTime=Thu Jul 11 00:00:00 CST 2019, time=2019-07-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=575525, encodeId=12695e5525a7, content=问下你的文章现在接收了吗？我的投出去当天编辑推荐换他写的题目，并在摘要里从新加了一句话她加的话后重新投稿，重投二天后目前还在with editor，请问这个状态持续多久才能under review莫名字阔以吗 2019-08-16 00:00:00 发表: 可以问问了吧，他家挺快的啊，我当天就邀请审稿人了, beContent=莫名字阔以吗 2019-08-16 00:00:00 发表: 可以问问了吧，他家挺快的啊，我当天就邀请审稿人了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKbuMTogxT82iaafNzKneXa0pOJ6F14K57vK0W8Loxkibl2ZfjgtmlJbEFbpIv4qpjuqhhoK05tzibWw/132, createdBy=89622105481, createdName=一梦十寒, createdTime=Thu Aug 29 00:00:00 CST 2019, time=2019-08-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1227018, encodeId=281c122e0181b, content=请问Pharmacological Research的投稿网址在哪里可以找到呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b9775425788, createdName=ms9000002027311925, createdTime=Fri Jun 17 12:57:56 CST 2022, time=2022-06-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1232803, encodeId=41b11232803d1, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：拒稿后修改重新投稿;综述 经验分享：请问一下友友，这个杂志送外审后拒稿率高吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220703/ac30326af85e40a198bd59fb829e58e1/640aec889c7a46399361ab5ac03a87e9.jpg, createdBy=720f2366630, createdName=待我慢慢, createdTime=Sat Jul 16 15:37:22 CST 2022, time=2022-07-16, status=1, ipAttribution=)]

2022-07-16 待我慢慢

审稿速度:3.0 | 投稿命中率:50.0
偏重的研究方向：拒稿后修改重新投稿;综述
经验分享：请问一下友友，这个杂志送外审后拒稿率高吗？

44 3

展开3条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务